Pharmacokinetic and pharmacodynamic considerations in gene therapy
Authors:
- Hidetaka AkitaHAHidetaka Akita
- Hideyoshi HarashimaHHHideyoshi Harashima
- 1 November 2003
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 8 (21) , 990-996
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- The Effect of Cell Division on the Cellular Dynamics of Microinjected DNA and DextranMolecular Therapy, 2002
- Methylation of Histone H4 at Arginine 3 Facilitating Transcriptional Activation by Nuclear Hormone ReceptorScience, 2001
- Arginine-rich PeptidesJournal of Biological Chemistry, 2001
- Stabilized plasmid-lipid particles for systemic gene therapyGene Therapy, 2000
- Stabilized Plasmid–Lipid Particles: Pharmacokinetics and Plasmid Delivery to Distal Tumors following Intravenous InjectionJournal of Drug Targeting, 2000
- Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transferGene Therapy, 1999
- DNA vector chemistry: The covalent attachment of signal peptides to plasmid DNANature Biotechnology, 1998
- Differential Expression and Sequence-specific Interaction of Karyopherin α with Nuclear Localization SequencesJournal of Biological Chemistry, 1997
- Fusogenic activity of SIV (Simian Immunodeficiency Virus) peptides located in the GP32 NH2 terminal domainBiochemical and Biophysical Research Communications, 1991
- pH-induced alterations in the fusogenic spike protein of Semliki Forest virus.Journal of Cell Biology, 1985